1. Home
  2. UDR vs MDGL Comparison

UDR vs MDGL Comparison

Compare UDR & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UDR Inc.

UDR

UDR Inc.

N/A

Current Price

$36.85

Market Cap

12.2B

Sector

Real Estate

ML Signal

N/A

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

N/A

Current Price

$432.56

Market Cap

10.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UDR
MDGL
Founded
1972
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.2B
10.0B
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
UDR
MDGL
Price
$36.85
$432.56
Analyst Decision
Hold
Strong Buy
Analyst Count
13
12
Target Price
$40.54
$674.45
AVG Volume (30 Days)
3.4M
332.7K
Earning Date
05-12-2026
05-19-2026
Dividend Yield
4.73%
N/A
EPS Growth
334.62
41.32
EPS
1.13
N/A
Revenue
$1,712,317,000.00
$180,133,000.00
Revenue This Year
$0.18
$58.70
Revenue Next Year
$3.14
$46.88
P/E Ratio
$32.58
N/A
Revenue Growth
2.42
N/A
52 Week Low
$32.94
$265.00
52 Week High
$45.56
$615.00

Technical Indicators

Market Signals
Indicator
UDR
MDGL
Relative Strength Index (RSI) 42.94 38.22
Support Level $36.57 $416.43
Resistance Level $37.04 $452.22
Average True Range (ATR) 0.72 18.19
MACD -0.12 1.47
Stochastic Oscillator 20.31 35.16

Price Performance

Historical Comparison
UDR
MDGL

About UDR UDR Inc.

UDR Inc is a real estate investment trust that owns, operates, acquires, renovates, develops, redevelops, disposes of, and manages multifamily apartment communities in targeted markets located in the United States. The company has two reportable segments; Same-Store Communities segment represents those communities acquired, developed, and stabilized; and Non-Mature Communities/Other segment represents those communities that do not meet the criteria to be included in Same-Store Communities, including, but not limited to, recently acquired, developed and redeveloped communities, and the non-apartment components of mixed-use properties. It generates key revenue from Same-Store Communities.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: